Azvudine
- Generic Name
- Azvudine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11FN6O4
- CAS Number
- 1011529-10-4
- Unique Ingredient Identifier
- IJ2XP0ID0K
- Background
Azvudine is under investigation in clinical trial NCT04668235 (Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (Sars-cov-2 Infected)).
- Indication
⑴用于与核苷逆转录酶抑制剂及非核苷逆转录酶抑制剂联用，治疗高病毒载量的成年HIV-1感染患者。
⑵用于治疗普通型新型冠状病毒肺炎（COVID-19）成年患者。
- Associated Conditions
- -
- Associated Therapies
- -
Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
- First Posted Date
- 2020-12-16
- Last Posted Date
- 2022-08-12
- Lead Sponsor
- HRH Pharmaceuticals Limited
- Target Recruit Count
- 180
- Registration Number
- NCT04668235
- Locations
- 🇧🇷
Santa Casa de Misericordia de Campos, Campos Dos Goytacazes, RJ, Brazil
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath